US Patent 11759441 Biguanide compositions and methods of treating metabolic disorders
Patent 11759441 was granted and assigned to Anji Pharmaceuticals on September, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+46 properties)
Article (+532 characters)
US Patent 11759441 Biguanide compositions and methods of treating metabolic disorders
Article
Patent abstract
Provided herein are methods for treating certain conditions, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a biguanide or related heterocyclic compound, e.g., metformin. Also provided herein are biguanide or related heterocyclic compound compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Alain D. Baron
Mark S. Fineman
Nigel R. A. Beeley
Date of Patent
September 19, 2023
Patent Application Number
17375807
Date Filed
July 14, 2021
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11759441 Biguanide compositions and methods of treating metabolic disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
